{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:42:23Z","timestamp":1788298943950,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s12035-024-04080-0","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T02:08:35Z","timestamp":1711937315000},"page":"8668-8687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["EZH2 Promotes Glioma Cell Proliferation, Invasion, and Migration via Mir-142-3p\/KCNQ1OT1\/HMGB3 Axis"],"prefix":"10.1007","volume":"61","author":[{"given":"Yiming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4423-3009","authenticated-orcid":false,"given":"Baozhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,1]]},"reference":[{"key":"4080_CR1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA et al (2014) The epidemiology of glioma in adults: a state of the science review. Neuro Oncol 16:896\u2013913","journal-title":"Neuro Oncol"},{"key":"4080_CR2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.soncn.2018.10.001","volume":"34","author":"ME Davis","year":"2018","unstructured":"Davis ME (2018) Epidemiology and overview of Gliomas. Semin Oncol Nurs 34:420\u2013429","journal-title":"Semin Oncol Nurs"},{"key":"4080_CR3","first-page":"1365","volume":"24","author":"L Lin","year":"2017","unstructured":"Lin L, Cai J, Jiang C (2017) Recent advances in targeted therapy for Glioma. Curr Med Chem 24:1365\u20131381","journal-title":"Curr Med Chem"},{"key":"4080_CR4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcancer.2017.11.010","volume":"51","author":"O Gusyatiner","year":"2018","unstructured":"Gusyatiner O, Hegi ME (2018) Glioma epigenetics: from subclassification to novel treatment options. Semin Cancer Biol 51:50\u201358","journal-title":"Semin Cancer Biol"},{"key":"4080_CR5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fonc.2017.00045","volume":"7","author":"MJ Williams","year":"2017","unstructured":"Williams MJ, Singleton WG, Lowis SP, Malik K, Kurian KM (2017) Therapeutic targeting of histone modifications in Adult and Pediatric High-Grade Glioma. Front Oncol 7:45","journal-title":"Front Oncol"},{"key":"4080_CR6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12935-019-0982-z","volume":"19","author":"R Wang","year":"2019","unstructured":"Wang R, Cheng L, Yang X, Chen X, Miao Y, Qiu Y, Zhou Z (2019) Histone methyltransferase SUV39H2 regulates cell growth and chemosensitivity in glioma via regulation of hedgehog signaling. Cancer Cell Int 19:269","journal-title":"Cancer Cell Int"},{"key":"4080_CR7","doi-asserted-by":"crossref","first-page":"114419","DOI":"10.1016\/j.ejmech.2022.114419","volume":"238","author":"J Zeng","year":"2022","unstructured":"Zeng J, Zhang J, Sun Y, Wang J, Ren C, Banerjee S, Ouyang L, Wang Y (2022) Targeting EZH2 for cancer therapy: from current progress to novel strategies. Eur J Med Chem 238:114419","journal-title":"Eur J Med Chem"},{"key":"4080_CR8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12032-023-02025-6","volume":"40","author":"Y Liu","year":"2023","unstructured":"Liu Y, Yang Q (2023) The roles of EZH2 in cancer and its inhibitors. Med Oncol 40:167","journal-title":"Med Oncol"},{"key":"4080_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jb\/mvab007","volume":"170","author":"S Hanaki","year":"2021","unstructured":"Hanaki S, Shimada M (2021) Targeting EZH2 as cancer therapy. J Biochem 170:1\u20134","journal-title":"J Biochem"},{"key":"4080_CR10","doi-asserted-by":"crossref","first-page":"112532","DOI":"10.1016\/j.biopha.2021.112532","volume":"146","author":"MDA Paskeh","year":"2022","unstructured":"Paskeh MDA, Mehrabi A, Gholami MH, Zabolian A, Ranjbar E, Saleki H, Ranjbar A, Hashemi M et al (2022) EZH2 as a new therapeutic target in brain tumors: molecular landscape, therapeutic targeting and future prospects. Biomed Pharmacother 146:112532","journal-title":"Biomed Pharmacother"},{"key":"4080_CR11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","volume":"13","author":"R Duan","year":"2020","unstructured":"Duan R, Du W, Guo W (2020) EZH2: a novel target for cancer treatment. J Hematol Oncol 13:104","journal-title":"J Hematol Oncol"},{"key":"4080_CR12","first-page":"3204","volume":"24","author":"WX Qin","year":"2020","unstructured":"Qin WX, Shi Y, Zhu D, Li YP, Chen YH, Cui J, Cui GY, Pan JX et al (2020) EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p. Eur Rev Med Pharmacol Sci 24:3204\u20133214","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4080_CR13","doi-asserted-by":"crossref","first-page":"25167","DOI":"10.18632\/oncotarget.15531","volume":"8","author":"W Li","year":"2017","unstructured":"Li W, Miao X, Liu L, Zhang Y, Jin X, Luo X, Gao H, Deng X (2017) Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT\/beta-catenin pathway in GBM. Oncotarget 8:25167\u201325176","journal-title":"Oncotarget"},{"key":"4080_CR14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.18388\/abp.2015_1072","volume":"62","author":"K Rolle","year":"2015","unstructured":"Rolle K (2015) miRNA multiplayers in glioma. From bench to bedside. Acta Biochim Pol 62:353\u2013365","journal-title":"Acta Biochim Pol"},{"key":"4080_CR15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bbrc.2018.01.076","volume":"498","author":"G Li","year":"2018","unstructured":"Li G, Yang H, Han K, Zhu D, Lun P, Zhao Y (2018) A novel circular RNA, hsa_circ_0046701, promotes carcinogenesis by increasing the expression of mir-142-3p target ITGB8 in glioma. Biochem Biophys Res Commun 498:254\u2013261","journal-title":"Biochem Biophys Res Commun"},{"key":"4080_CR16","first-page":"dju162","volume":"106","author":"S Xu","year":"2014","unstructured":"Xu S, Wei J, Wang F, Kong LY, Ling XY, Nduom E, Gabrusiewicz K, Doucette T et al (2014) Effect of mir-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. J Natl Cancer Inst 106:dju162","journal-title":"J Natl Cancer Inst"},{"key":"4080_CR17","first-page":"4493","volume":"11","author":"C Li","year":"2018","unstructured":"Li C, Feng S, Chen L (2018) MicroRNA-142-3p inhibits proliferation and induces apoptosis by targeting the high-mobility group box 1 via the Wnt\/beta-catenin signaling pathway in glioma. Int J Clin Exp Pathol 11:4493\u20134502","journal-title":"Int J Clin Exp Pathol"},{"key":"4080_CR18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-1-4939-3378-5_21","volume":"1402","author":"MD Paraskevopoulou","year":"2016","unstructured":"Paraskevopoulou MD, Hatzigeorgiou AG (2016) Analyzing MiRNA-LncRNA interactions. Methods Mol Biol 1402:271\u2013286","journal-title":"Methods Mol Biol"},{"key":"4080_CR19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-0716-1697-0_21","volume":"2372","author":"D Karagkouni","year":"2021","unstructured":"Karagkouni D, Karavangeli A, Paraskevopoulou MD, Hatzigeorgiou AG (2021) Characterizing miRNA-lncRNA interplay. Methods Mol Biol 2372:243\u2013262","journal-title":"Methods Mol Biol"},{"key":"4080_CR20","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3390\/biom11111602","volume":"11","author":"P Cagle","year":"2021","unstructured":"Cagle P, Qi Q, Niture S, Kumar D (2021) KCNQ1OT1: an oncogenic long noncoding RNA. Biomolecules 11:1602","journal-title":"Biomolecules"},{"key":"4080_CR21","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2020.3762","author":"J Wen","year":"2020","unstructured":"Wen J, Ding Y, Zheng S, Li X, Xiao Y (2020) Sevoflurane suppresses Glioma Cell Proliferation, Migration, and Invasion both in Vitro and in vivo partially Via regulating KCNQ1OT1\/miR-146b-5p\/STC1 Axis. Cancer Biother Radiopharm. https:\/\/doi.org\/10.1089\/cbr.2020.3762","journal-title":"Cancer Biother Radiopharm"},{"key":"4080_CR22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10571-020-00958-4","volume":"42","author":"W Wang","year":"2022","unstructured":"Wang W, Han S, Gao W, Feng Y, Li K, Wu D (2022) Long noncoding RNA KCNQ1OT1 confers Gliomas Resistance to Temozolomide and enhances cell growth by retrieving PIM1 from miR-761. Cell Mol Neurobiol 42:695\u2013708","journal-title":"Cell Mol Neurobiol"},{"key":"4080_CR23","unstructured":"In: Guide for the Care and Use of Laboratory animals. 8th edn. Washington (DC); (2011)"},{"key":"4080_CR24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"4080_CR25","doi-asserted-by":"crossref","first-page":"14596","DOI":"10.1111\/jcmm.16089","volume":"24","author":"X Zhang","year":"2020","unstructured":"Zhang X, Xue C, Cui X, Zhou Z, Fu Y, Yin X, Wu S, Gong Y et al (2020) Circ_0075829 facilitates the progression of pancreatic carcinoma by sponging mir-1287-5p and activating LAMTOR3 signalling. J Cell Mol Med 24:14596\u201314607","journal-title":"J Cell Mol Med"},{"key":"4080_CR26","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z (2019) GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res 47:W556\u2013W560","journal-title":"Nucleic Acids Res"},{"key":"4080_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Zhang KN, Wang Q, Li G, Zeng F, Zhang Y, Wu F, Chai R et al (2021) Chinese Glioma Genome Atlas (CGGA): a Comprehensive Resource with functional genomic data from Chinese glioma patients. Genomics Proteom Bioinf 19:1\u201312","journal-title":"Genomics Proteom Bioinf"},{"key":"4080_CR28","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH (2014) starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 42:D92\u201397","journal-title":"Nucleic Acids Res"},{"key":"4080_CR29","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/bib\/bbx042","volume":"19","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Tao Y, Liao Q (2018) Long noncoding RNA: a crosslink in biological regulatory network. Brief Bioinform 19:930\u2013945","journal-title":"Brief Bioinform"},{"key":"4080_CR30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fncel.2017.00084","volume":"11","author":"W Gong","year":"2017","unstructured":"Gong W, Zheng J, Liu X, Liu Y, Guo J, Gao Y, Tao W, Chen J et al (2017) Knockdown of long non-coding RNA KCNQ1OT1 restrained glioma cells\u2019 malignancy by activating miR-370\/CCNE2 Axis. Front Cell Neurosci 11:84","journal-title":"Front Cell Neurosci"},{"key":"4080_CR31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/jcp.30946","volume":"238","author":"A Maklad","year":"2023","unstructured":"Maklad A, Sedeeq M, Wilson R, Heath JA, Gueven N, Azimi I (2023) LIN28 expression and function in medulloblastoma. J Cell Physiol 238:533\u2013548","journal-title":"J Cell Physiol"},{"key":"4080_CR32","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1007\/s10753-021-01431-0","volume":"44","author":"SY Ni","year":"2021","unstructured":"Ni SY, Xu WT, Liao GY, Wang YL, Li J (2021) LncRNA HOTAIR promotes LPS-Induced inflammation and apoptosis of Cardiomyocytes via Lin28-Mediated PDCD4 Stability. Inflammation 44:1452\u20131463","journal-title":"Inflammation"},{"key":"4080_CR33","first-page":"10874","volume":"23","author":"WL Chen","year":"2019","unstructured":"Chen WL, Jiang L, Wang JS, Liao CX (2019) Circ-0001801 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition (EMT) in glioblastoma by regulating miR-628-5p\/HMGB3 axis. Eur Rev Med Pharmacol Sci 23:10874\u201310885","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4080_CR34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/cbf.3355","volume":"36","author":"J Liu","year":"2018","unstructured":"Liu J, Wang L, Li X (2018) HMGB3 promotes the proliferation and metastasis of glioblastoma and is negatively regulated by miR-200b-3p and miR-200c-3p. Cell Biochem Funct 36:357\u2013365","journal-title":"Cell Biochem Funct"},{"key":"4080_CR35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2990.2010.01132.x","volume":"37","author":"F Orzan","year":"2011","unstructured":"Orzan F, Pellegatta S, Poliani PL, Pisati F, Caldera V, Menghi F, Kapetis D, Marras C et al (2011) Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells. Neuropathol Appl Neurobiol 37:381\u2013394","journal-title":"Neuropathol Appl Neurobiol"},{"key":"4080_CR36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/jcmm.16149","volume":"25","author":"YN Chen","year":"2021","unstructured":"Chen YN, Hou SQ, Jiang R, Sun JL, Cheng CD, Qian ZR (2021) EZH2 is a potential prognostic predictor of glioma. J Cell Mol Med 25:925\u2013936","journal-title":"J Cell Mol Med"},{"key":"4080_CR37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.18632\/oncotarget.13478","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Yu X, Chen L, Zhang Z, Feng S (2017) EZH2 overexpression is associated with poor prognosis in patients with glioma. Oncotarget 8:565\u2013573","journal-title":"Oncotarget"},{"key":"4080_CR38","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.12659\/MSM.909814","volume":"24","author":"T Cheng","year":"2018","unstructured":"Cheng T, Xu Y (2018) Effects of enhancer of Zeste Homolog 2 (EZH2) expression on Brain Glioma Cell Proliferation and Tumorigenesis. Med Sci Monit 24:7249\u20137255","journal-title":"Med Sci Monit"},{"key":"4080_CR39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nm.4293","volume":"23","author":"F Mohammad","year":"2017","unstructured":"Mohammad F, Weissmann S, Leblanc B, Pandey DP, Hojfeldt JW, Comet I, Zheng C, Johansen JV et al (2017) EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas. Nat Med 23:483\u2013492","journal-title":"Nat Med"},{"key":"4080_CR40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10014-015-0245-1","volume":"33","author":"V Sharma","year":"2016","unstructured":"Sharma V, Purkait S, Takkar S, Malgulwar PB, Kumar A, Pathak P, Suri V, Sharma MC et al (2016) Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors. Brain Tumor Pathol 33:117\u2013128","journal-title":"Brain Tumor Pathol"},{"key":"4080_CR41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.molcel.2013.11.009","volume":"52","author":"GY Chiou","year":"2013","unstructured":"Chiou GY, Chien CS, Wang ML, Chen MT, Yang YP, Yu YL, Chien Y, Chang YC et al (2013) Epigenetic regulation of the miR142-3p\/interleukin-6 circuit in glioblastoma. Mol Cell 52:693\u2013706","journal-title":"Mol Cell"},{"key":"4080_CR42","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41418-018-0208-2","volume":"26","author":"Y Li","year":"2019","unstructured":"Li Y, He Q, Wen X, Hong X, Yang X, Tang X, Zhang P, Lei Y et al (2019) EZH2-DNMT1-mediated epigenetic silencing of mir-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma. Cell Death Differ 26:1089\u20131106","journal-title":"Cell Death Differ"},{"key":"4080_CR43","doi-asserted-by":"crossref","first-page":"910543","DOI":"10.3389\/fnmol.2022.910543","volume":"15","author":"H Wu","year":"2022","unstructured":"Wu H, Wei M, Li Y, Ma Q, Zhang H (2022) Research Progress on the Regulation mechanism of Key Signal pathways affecting the prognosis of Glioma. Front Mol Neurosci 15:910543","journal-title":"Front Mol Neurosci"},{"key":"4080_CR44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/bib\/bbv031","volume":"17","author":"F Ferre","year":"2016","unstructured":"Ferre F, Colantoni A, Helmer-Citterich M (2016) Revealing protein-lncRNA interaction. Brief Bioinform 17:106\u2013116","journal-title":"Brief Bioinform"},{"key":"4080_CR45","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.biocel.2013.02.006","volume":"45","author":"J Zhou","year":"2013","unstructured":"Zhou J, Ng SB, Chng WJ (2013) LIN28\/LIN28B: an emerging oncogenic driver in cancer stem cells. Int J Biochem Cell Biol 45:973\u2013978","journal-title":"Int J Biochem Cell Biol"},{"key":"4080_CR46","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.3390\/cancers15123241","volume":"15","author":"T Knowles","year":"2023","unstructured":"Knowles T, Huang T, Qi J, An S, Burket N, Cooper S, Nazarian J, Saratsis AM (2023) LIN28B and Let-7 in diffuse midline glioma: a review. Cancers (Basel) 15:3241","journal-title":"Cancers (Basel)"},{"key":"4080_CR47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neo.2020.04.001","volume":"22","author":"D Chen","year":"2020","unstructured":"Chen D, Cox J, Annam J, Weingart M, Essien G, Rathi KS, Rokita JL, Khurana P et al (2020) LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase. Neoplasia 22:231\u2013241","journal-title":"Neoplasia"},{"key":"4080_CR48","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s11010-020-04015-y","volume":"476","author":"B Wen","year":"2021","unstructured":"Wen B, Wei YT, Zhao K (2021) The role of high mobility group protein B3 (HMGB3) in tumor proliferation and drug resistance. Mol Cell Biochem 476:1729\u20131739","journal-title":"Mol Cell Biochem"},{"key":"4080_CR49","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/iub.2383","volume":"72","author":"K Yin","year":"2020","unstructured":"Yin K, Liu X (2020) CircMMP1 promotes the progression of glioma through miR-433\/HMGB3 axis in vitro and in vivo. IUBMB Life 72:2508\u20132524","journal-title":"IUBMB Life"},{"key":"4080_CR50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11060-021-03814-7","volume":"154","author":"B Xiao","year":"2021","unstructured":"Xiao B, Lv SG, Wu MJ, Shen XL, Tu W, Ye MH, Zhu XG (2021) Circ_CLIP2 promotes glioma progression through targeting the miR-195-5p\/HMGB3 axis. J Neurooncol 154:131\u2013144","journal-title":"J Neurooncol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04080-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04080-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04080-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T11:23:15Z","timestamp":1729596195000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04080-0"}},"subtitle":["Running Title: EZH2 Promotes Glioma cell Malignant Behaviors"],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["4080"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04080-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,1]]},"assertion":[{"value":"27 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tthe study procedure was approved by the Ethics Committee of Beijing Fengtai You\u2019anmen Hospital (Approval number: 2022-08-053). All animal experiment schemes were approved by the Animal Ethics Committee of Beijing Fengtai You\u2019anmen Hospital (Approval number: 2023-03-032) and implemented based on the <i>Guide for the Care and Use of Laboratory Animals<\/i> [].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The informed consent from all participants was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}